You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

JAK2 wild type

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HR+/HER2- Advanced Breast Cancer, Targeted Therapy Trial in Beijing (Everolimus, Chidamide, Endocrine therapy)

Recruiting
  • HR+/HER2- Advanced Breast Cancer
  • Targeted Therapy
  • Beijing, Beijing, China
    National Cancer Center/National Clinical Research Center for Can
Aug 1, 2023

Diabetes, Type 1 Trial (Abrocitinib 200 MG Oral Tablet, Ritlecitinib, Placebo)

Not yet recruiting
  • Diabetes Mellitus, Type 1
  • Abrocitinib 200 MG Oral Tablet
  • +2 more
  • (no location specified)
Feb 21, 2023

Ovarian Cancer, Resistant BRCA Wild-Type Ovarian Cancer Trial in Birmingham (Cohort 1: Dose Escalation, Cohort 2: Dose

Terminated
  • Ovarian Cancer
  • Resistant BRCA Wild-Type Ovarian Cancer
  • Cohort 1: Dose Escalation
  • Cohort 2: Dose Escalation
  • Birmingham, Alabama
    University of Alabama at Birmingham
Apr 29, 2022

Colorectal Cancer Trial (SOT101, Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • (no location specified)
Dec 5, 2022

Advanced Breast Cancer, HER2/Neu Negative, Triple-Negative Breast Cancer Trial in Stanford (Talazoparib Tosylate)

Active, not recruiting
  • Advanced Breast Cancer
  • +2 more
  • Talazoparib Tosylate
  • Stanford, California
    Stanford University Hospitals and Clinics
Nov 16, 2022

Childhood Astrocytoma, Childhood Atypical Teratoid/Rhabdoid Tumor, Diffuse Intrinsic Pontine Glioma Trial in Rochester

Active, not recruiting
  • Childhood Astrocytoma
  • +9 more
  • Laboratory Biomarker Analysis
  • +2 more
  • Rochester, Minnesota
    Mayo Clinic
Sep 8, 2022

Astrocytoma, Grade IV, Glioblastoma, Giant Cell Glioblastoma Trial in United States (CYNK-001 systemic and Intra cavity

Recruiting
  • Astrocytoma, Grade IV
  • +3 more
  • CYNK-001 systemic and Intra cavity administration
  • Duarte, California
  • +5 more
Jan 20, 2023

Recurrent Glioblastoma, IDH-Wildtype, Recurrent WHO Grade 2 Glioma, Recurrent WHO Grade 3 Glioma Trial (Biospecimen Collection,

Not yet recruiting
  • Recurrent Glioblastoma, IDH-Wildtype
  • +2 more
  • Biospecimen Collection
  • +2 more
  • (no location specified)
May 13, 2023

Colorectal Cancer Stage IV Trial in Napoli (Panitumumab)

Completed
  • Colorectal Cancer Stage IV
  • Napoli, Italy
    Istituto Nazionale Tumori di Napoli - IRCCS - Fondazione G. Pasc
Apr 6, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Los Angeles (drug, other, biological)

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Aug 5, 2022

Solid Tumor Trial in United States (ASTX295)

Recruiting
  • Solid Tumor
  • Duarte, California
  • +9 more
Nov 18, 2022

Ovarian Cancer by FIGO Stage, Ovarian Cancer Stage III, Ovarian Cancer Stage IV Trial in Seoul (Oregovomab, Bevacizumab,

Recruiting
  • Ovarian Cancer by FIGO Stage
  • +2 more
  • Oregovomab
  • +3 more
  • Daegu, Korea, Republic of
  • +5 more
Oct 20, 2022

NSCLC, Squamous Non-small-cell Lung Cancer, Squamous Non-Small Cell Tumor of Lung Trial in United States (sapanisertib)

Recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Davis, California
  • +13 more
Nov 7, 2022

Colorectal Cancer Trial in Madrid (FOLFOX regimen, Panitumumab, Bevacizumab)

Recruiting
  • Colorectal Cancer
  • FOLFOX regimen
  • +3 more
  • Madrid, Spain
    Spanish Cooperative Group for the Treatment of Digestive Tumors
Mar 8, 2022

Stage IV Melanoma, Stage III Melanoma Trial in Jette (Trametinib, Dabrafenib)

Recruiting
  • Stage IV Melanoma
  • Stage III Melanoma
  • Jette, Brussels, Belgium
    Universitair Ziekenhuis Brussel
Sep 29, 2021

Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy, Transthyretin-Related (ATTR) Familial Amyloid Cardiomyopathy,

Recruiting
  • Transthyretin-Related (ATTR) Familial Amyloid Polyneuropathy
  • +2 more
  • NTLA-2001
  • Paris, France
  • +3 more
Nov 29, 2022

Colo-rectal Cancer, Capecitabine, Cetuximab Trial in Chengdu (mCapOX plus cetuximab, mFOLFOX6 plus cetuximab)

Recruiting
  • Colo-rectal Cancer
  • +2 more
  • mCapOX plus cetuximab
  • mFOLFOX6 plus cetuximab
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Sep 1, 2021

Metastatic Colorectal Cancer Trial in United States (Trastuzumab, Cetuximab, Neratinib)

Active, not recruiting
  • Metastatic Colorectal Cancer
  • Anaheim, California
  • +47 more
Mar 28, 2022

Covid19 Trial in London

Completed
  • Covid19
    • London, United Kingdom
      hVIVO Services Ltd, QMB Bioenterprise building
    Sep 7, 2021

    Malignant Salivary Gland Cancer, Salivary Gland Cancer Trial in Tampa, Chicago, Ann Arbor (APG-115, Carboplatin)

    Recruiting
    • Malignant Salivary Gland Cancer
    • Salivary Gland Cancer
    • Tampa, Florida
    • +2 more
    Feb 10, 2022

    Colorectal Cancer Trial in Pisa (Regorafenib, Panitumumab)

    Recruiting
    • Colorectal Cancer
    • Pisa, PI, Italy
      U.O. Oncologia 2 Universitaria
    Aug 3, 2022

    Ovarian Cancer Trial in Italy (Olaparib Oral Product)

    Recruiting
    • Ovarian Cancer
    • Olaparib Oral Product
    • Avellino, Italy
    • +4 more
    Feb 22, 2022

    Pancreatic Tumors, Solid Tumors, Biliary Tract Cancer Trial (BI 907828)

    Not yet recruiting
    • Pancreatic Neoplasms
    • +2 more
    • BI 907828
    • (no location specified)
    Aug 22, 2022

    Pancreatic Adenocarcinoma, Stage III Pancreatic Cancer AJCC v8, Stage IV Pancreatic Cancer AJCC v8 Trial in Chicago

    Terminated
    Has Results
    • Pancreatic Adenocarcinoma
    • +2 more
    • Pembrolizumab
    • Wild-type Reovirus
    • Chicago, Illinois
      Northwestern University
    Sep 6, 2022

    Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

    Not yet recruiting
    • Platinum-Resistant Fallopian Tube Carcinoma
    • +5 more
    • Biopsy
    • +4 more
    • Duarte, California
      City of Hope Medical Center
    Jan 3, 2023